Home NDC 10922-825 Finacea
Product NDC 10922-825
11-digit product format 109220825
Labeler code 10922
Product ID 10922-825_a7594a20-f46e-4b33-91d5-410cc5e97b8d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name azelaic acid
Dosage form GEL
Route TOPICAL
Labeler Intendis Inc.
Application NDA021470
Marketing category NDA
Marketing start 2004-12-24
Marketing end 0000-00-00
Substance AZELAIC ACID
Active strength 0 g/g
Pharmacologic classes Decreased Protein Synthesis [PE],Decreased Sebaceous Gland Activity [PE]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 10922-825-02 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 10922-825-02 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 10922-825-02 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 10922-825-02 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 10922-825-02 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 10922-825-02 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 10922-825-02 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 10922-825-02 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 10922-825-02 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 10922-825-02 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 10922-825-02 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 10922-825-02 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 10922-825-02 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 10922-825-02 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 10922-825-02 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 10922-825-02 fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 10922-825-02 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 10922-825-02 bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 10922-825-02 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 10922-825-02 e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 10922-825-02 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 10922-825-02 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021470-001 FINACEA AZELAIC ACID 15% GEL / TOPICAL AB RLD, RS 2002-12-24
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N021470-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N021470-001 FINACEA 15% GEL / TOPICAL AB RLD, RS 2002-12-24 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 10922-825-02 Finacea 50 g in 1 TUBE GEL 50 5 10922-825-02 Finacea 1 in 1 CARTON GEL 1 5
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded AZELAIC ACID ACTIVE INGREDIENT F2VW3D43YT FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 AZELAIC ACID ACTIVE MOIETY F2VW3D43YT FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 1,2-DIARACHIDOYL-SN-GLYCERO-3-PHOSPHOCHOLINE INACTIVE INGREDIENT HE0P2D9ZLS FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 BEHENTRIMONIUM METHOSULFATE INACTIVE INGREDIENT 5SHP745C61 FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 BENZOIC ACID INACTIVE INGREDIENT 8SKN0B0MIM FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 CERAMIDE 1 INACTIVE INGREDIENT 5THT33P7X7 FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 CERAMIDE 3 INACTIVE INGREDIENT 4370DF050B FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 CERAMIDE 6 II INACTIVE INGREDIENT F1X8L2B00J FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 CETOSTEARYL ALCOHOL INACTIVE INGREDIENT 2DMT128M1S FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 CETYL ALCOHOL INACTIVE INGREDIENT 936JST6JCN FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 CHOLESTEROL INACTIVE INGREDIENT 97C5T2UQ7J FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 DIMETHICONE INACTIVE INGREDIENT 92RU3N3Y1O FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 GLYCERYL MONOSTEARATE INACTIVE INGREDIENT 230OU9XXE4 FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 HYALURONIC ACID INACTIVE INGREDIENT S270N0TRQY FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 MEDIUM-CHAIN TRIGLYCERIDES INACTIVE INGREDIENT C9H2L21V7U FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 PHYTOSPHINGOSINE INACTIVE INGREDIENT GIN46U9Q2Q FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 POLYACRYLIC ACID (250000 MW) INACTIVE INGREDIENT 9G2MAD7J6W FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 POLYGLYCERYL-3 DIISOSTEARATE INACTIVE INGREDIENT 46P231IQV8 FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 POLYOXYL 20 CETOSTEARYL ETHER INACTIVE INGREDIENT YRC528SWUY FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 POLYOXYL 40 STEARATE INACTIVE INGREDIENT 13A4J4NH9I FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 POLYSORBATE 20 INACTIVE INGREDIENT 7T1F30V5YH FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 POTASSIUM PHOSPHATE, DIBASIC INACTIVE INGREDIENT CI71S98N1Z FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 POTASSIUM PHOSPHATE, UNSPECIFIED FORM INACTIVE INGREDIENT B7862WZ632 FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 SODIUM LAUROYL LACTYLATE INACTIVE INGREDIENT 7243K85WFO FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 STEARYL ALCOHOL INACTIVE INGREDIENT 2KR89I4H1Y FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 WATER INACTIVE INGREDIENT 059QF0KO0R FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 AZELAIC ACID ACTIVE INGREDIENT F2VW3D43YT FINACEA (AZELAIC ACID) GEL [PHYSICIANS TOTAL CARE, INC.] 1 AZELAIC ACID ACTIVE MOIETY F2VW3D43YT FINACEA (AZELAIC ACID) GEL [PHYSICIANS TOTAL CARE, INC.] 1 BENZOIC ACID INACTIVE INGREDIENT 8SKN0B0MIM FINACEA (AZELAIC ACID) GEL [PHYSICIANS TOTAL CARE, INC.] 1 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K FINACEA (AZELAIC ACID) GEL [PHYSICIANS TOTAL CARE, INC.] 1 MEDIUM-CHAIN TRIGLYCERIDES INACTIVE INGREDIENT C9H2L21V7U FINACEA (AZELAIC ACID) GEL [PHYSICIANS TOTAL CARE, INC.] 1 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H FINACEA (AZELAIC ACID) GEL [PHYSICIANS TOTAL CARE, INC.] 1 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 FINACEA (AZELAIC ACID) GEL [PHYSICIANS TOTAL CARE, INC.] 1 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I FINACEA (AZELAIC ACID) GEL [PHYSICIANS TOTAL CARE, INC.] 1 WATER INACTIVE INGREDIENT 059QF0KO0R FINACEA (AZELAIC ACID) GEL [PHYSICIANS TOTAL CARE, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 10922-825 FINACEA (AZELAIC ACID) GEL FINACEA (AZELAIC ACID) KIT [INTENDIS INC.] 5 Legacy NDC, 2 package rows 20130507_63773349-0295-4d56-a72e-0d7cade88ddb.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Status 10922-825-02 10922082502 50 g in 1 TUBE 50 g Historical